Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. (Q38351933)

2 September 2017

Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. (English)

1 reference

2 September 2017

0 references

2

Thomas Benzing

1 reference

2 September 2017

Beate Fisslthaler

1

1 reference

PubMed ID

12895435

2 September 2017

Rudi Busse

series ordinal

3

1 reference

PubMed ID

12895435

2 September 2017

Ingrid Fleming

series ordinal

4

1 reference

2 September 2017

1 June 2003

1 reference

2 September 2017

1 reference

2 September 2017

8

1 reference

2 September 2017

4

1 reference

2 September 2017

253-261

1 reference

Signalling through the insulin receptor

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Pharmacological modulation of endothelial function by insulin in the rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Inhibitory effects of insulin on cytosolic Ca2+ level and contraction in the rat aorta. Endothelium-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin-stimulated glucose transport inhibits Ca2+ influx and contraction in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

The vasodilating effect of insulin is dependent on local glucose uptake: a double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Distinct receptors for IGF-I, IGF-II, and insulin are present on bovine capillary endothelial cells and large vessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Physiological mechanisms regulating the expression of endothelial-type NO synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Endothelial nitric oxide synthase gene sequence variations and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Role of Sp1 in transcriptional activation of human nitric oxide synthase type III gene

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Insulin activates a PD 098059-sensitive kinase that is involved in the regulation of p70S6K and PHAS-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Characterization of the human endothelial nitric-oxide synthase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

CsA and FK506 up-regulate eNOS expression: role of reactive oxygen species and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

Nitric oxide, nitric oxide synthase, and hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-8603%2803%2900042-9

7 January 2021

10.1016/S1089-8603(03)00042-9

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

12895435